Courses

  • sfwd-courses

    Orthopedic and rehabilitative management of SMA complications

    This activity is supported by an independent educational grant from Biogen MA, Inc. Information

    0
  • sfwd-courses

    Rehabilitación para adolescentes y adultos con AME

    Esta actividad está respaldada por una subvención educativa independiente de Biogen MA, Inc. Información

    0
  • sfwd-courses

    SMA Expert Exchange: Emerging treatments in clinical practice | Post meeting (RU)

    Please login with your Google, LinkedIn, or email address to continue.

    0
  • sfwd-courses

    SMA Expert Exchange: Emerging treatments in clinical practice | Post meeting

    Please login with your Google, LinkedIn, or email address to continue.

    0
  • sfwd-courses

    Managing bone and bone marrow involvement in neuroblastoma with anti-GD2 therapy | On-demand

    This activity is supported by an independent educational grant from Y-mAbs Therapeutics, Inc, USA. Information

    0
  • sfwd-courses

    Managing bone and bone marrow involvement in neuroblastoma with anti-GD2 therapy | Post-symposium

    Thank you for participating this symposium. Tape “Take this course” button to earn CME credit. This activity is supported by…

    0
  • sfwd-courses

    Interactive patient case discussions in neuroblastoma immunotherapy

    This activity is supported by an independent educational grant from Y-mAbs Therapeutics, Inc. Information

    0
  • sfwd-courses

    Interactive patient case discussions in neuroblastoma immunotherapy (nurse)

    0
  • sfwd-courses

    Interactive patient case discussions in neuroblastoma immunotherapy (1 ECMEC)

    0
  • sfwd-courses

    Interactive patient case discussions in neuroblastoma immunotherapy (1 AMA PRA Category 1 credits non-phys)

    0
  • sfwd-courses

    Interactive patient case discussions in neuroblastoma immunotherapy (1 AMA PRA Category 1 credits)

    0
  • sfwd-courses

    Expert insights on biomarker testing in advanced personalized NSCLC care

    This activity is supported by independent educational grant from EMD Serono. Information

    0
  • sfwd-courses

    Expert insights on biomarker testing in advanced personalized NSCLC care (1.25 AMA PRA credits)

    Physician continuing medical education (AMA) The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA…

    0
  • sfwd-courses

    Expert insights on biomarker testing in advanced personalized NSCLC care (1.00 AMA PRA credits)

    Physician continuing medical education (AMA) The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA…

    0
  • sfwd-courses

    Expert insights on biomarker testing in advanced personalized NSCLC care (0.75 AMA PRA credits)

    Physician continuing medical education (AMA) The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA…

    0
  • sfwd-courses

    Expert insights on biomarker testing in advanced personalized NSCLC care (0.50 AMA PRA credits)

    Physician continuing medical education (AMA) The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA…

    0
  • sfwd-courses

    Targeting MET in advanced NSCLC care: A multidisciplinary perspective

    This activity is supported by an independent educational grant from Merck KGaA. Information

    0
  • sfwd-courses

    SMA Expert Exchange: Novel treatments in clinical practice | Oman (Post-assessment and evaluation)

    Thank you for participating in this event being held on October 28 & 29, 2022, a 1.5-day programme comprising engaging…

    0
  • sfwd-courses

    Interactive patient case discussions in neuroblastoma immunotherapy

    Thank you for participating in this event held on September 28, 2022. Please tap “Take this Course” button to login…

    0
  • sfwd-courses

    SMA Expert Exchange: Novel treatments in clinical practice | Oman (Pre-assessment test)

    Thank you for participating in this event being held on October 28 & 29, 2022, a 1.5-day programme comprising engaging…

    0